BioSpace News Archive

Secarna Pharmaceuticals GmbH & Co. KG (“Secarna”), a biopharmaceutical company focusing on the discovery and development of next generation antisense oligonucleotide (ASO) therapies to address challenging or previously undruggable targets via its LNAplusTM platform, today announced that the Company signed a Research, Development and Transfer Agreement with Lipigon Pharmaceuticals AB (“Lipigon”).

Maryland Rye distiller advised by Johns Hopkins on WHO- and FDA-compliant manufacturing of vital sanitizer

This report analyzes and forecasts the impact of the current COVID-19 and associated economic crisis on the global medical devices and diagnostics (MD&D) market.

Wyss Institute researchers are confronting the coronavirus crisis on all fronts -‑ by rapidly developing much needed diagnostic and therapeutic inventions

RB is announcing the launch of the RB Fight for Access Fund to improve access to health, hygiene and nutrition for all.

Midwest Express Clinic wants to be the most convenient and easiest urgent care option in Northwest Indiana and Illinois.

CytomX Therapeutics, Inc. announced that on March 23, 2020, the Company granted its recently appointed senior vice president and chief financial officer, Carlos Campoy, an option to purchase a total of 350,000 shares of the Company’s common stock at an exercise price per share equal to $4.93, which was the closing trading price on March 23, 2020, the date of the grant.

The Covid-19 pandemic has shined a bright light on the need to manage patients remotely wherever possible. This need is especially acute in clinical trials as identified by the FDA.

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported its financial results for the year ended December 31, 2019.

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced the appointment of Steven Altschuler, M.D., as chairman of its board of directors.